Evidence map›Paper›PMID 41973755›Full record

Observational studyPLoS neglected tropical diseases2026

The dynamics of asymptomatic Plasmodium spp. infections following 10 years of malaria control interventions in Northern Sahelian Ghana.

Cecilia A Rios-Teran, Kathryn E Tiedje, Oscar Bangre, Samantha L Deed, Dionne C Argyropoulos, Kwadwo A Koram, Abraham R Oduro, Patrick O Ansah, Karen P Day

Abstract readObservational Study
In one paragraph

Observational study in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cecilia A Rios-TeranDepartment of Microbiology and Immunology, Bio21 Institute and The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Kathryn E TiedjeDepartment of Microbiology and Immunology, Bio21 Institute and The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-3305-0533
Oscar BangreNavrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Samantha L DeedDepartment of Microbiology and Immunology, Bio21 Institute and The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Dionne C ArgyropoulosDepartment of Microbiology and Immunology, Bio21 Institute and The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Kwadwo A KoramEpidemiology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Abraham R OduroNavrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Patrick O AnsahNavrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Karen P DayDepartment of Microbiology and Immunology, Bio21 Institute and The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-6115-6135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current interventions targeting malaria control in sub-Saharan Africa (SSA) are focused on Plasmodium falciparum, the most prevalent species infecting humans. Despite renewed efforts for malaria elimination in SSA, little attention has been paid to the neglected parasites P. malariae, P. ovale spp., and P. vivax and the impact of interventions like long-lasting insecticidal nets (LLINs), indoor residual spraying (IRS) with non-pyrethroid insecticides, and/or seasonal malaria chemoprevention (SMC) on these minor Plasmodium spp. To address this research gap, the aim of this observational study was to assess the impact of two sequential interventions, IRS and SMC combined with LLINs, on the Plasmodium spp. reservoir, with particular emphasis on the non-falciparum minor species, in Bongo District, an area characterized by high seasonal transmission in the Northern Sahelian belt of Ghana. Using an interrupted time-series study design, five age-stratified surveys, each of ~2,000 participants, were undertaken at the end of the wet seasons between 2012 and 2022. Across this 10-year study period, infections with P. malariae and P. ovale spp. were detected using a species-specific PCR targeting the 18S rRNA gene, while P. vivax was not detected. In 2015, following IRS, the prevalence of the minor Plasmodium spp. declined in all ages from baseline in 2012, with participants being significantly less likely to be infected with P. malariae (13.7% vs 1.4%) and P. ovale spp. (5.7% vs 0.4%). Despite this decline, in 2017, 32 months after IRS was discontinued and SMC was introduced, the prevalence of P. malariae (2.9%) and P. ovale spp. (4.0%) rebounded, with approximately a 2- and 10-fold increase, respectively. This rebound in the minor species was observed in all age groups, except for the younger children (< 5 years) targeted by SMC. Finally, when we examined this population in 2020 and 2022 after continued deployment of SMC, the prevalence of P. malariae continued to increase (7.4% and 5.8%), while the prevalence of P. ovale spp. declined (2.6% and 1.3%). Results show that both IRS and SMC were effective not only against P. falciparum but also reduced the prevalence of P. malariae and P. ovale spp. in Bongo District. Going forward, molecular diagnostics will be critical to identify changes in the submicroscopic reservoir of the minor Plasmodium spp. found in adolescents and adults and to achieve malaria elimination in this region of Ghana.

Indexed as

Asymptomatic InfectionsMalariaPlasmodiumAdolescentAdultChildChild, PreschoolFemaleGhanaHumansInfantInsecticide-Treated BednetsMaleMosquito ControlPrevalenceSeasons

Identifiers

PMID41973755
PMCPMC13099091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.